Cipepofol

DB16295ApprovedInvestigationalSmall moleculeAnesthetics, General

Cipepofol is an alkylphenol GABA-A positive allosteric modulator used for induction of general anesthesia in adults undergoing surgery. Cipepofol is an intravenous general anesthetic of the alkylphenol class, supplied as a sterile lipid emulsion, which is thought to act by positively modulating the inhibitory function of GABA at ligand-gated GABA-A receptors, similar to...

Mechanism: Pharmacologically active on GABA(A) Receptor
Curator reviewed
Primary indication: Cipepofol is indicated for induction of general anesthesia in adults undergoing surgery.Curator reviewed · 1 structured indication
Formula / weight: C₁₄H₂₀O · 204.313 g/mol (avg)
Also known as: Ciprofol · Cyclopropofol
Code names: HSK-3486 · HSK-3486, (R)-

Resolves to

Compound

UNIIM3WGS532VYCAS1637741-58-2ChEMBLCHEMBL4094894

Structure

InChIKeyBMEARIQHWSVDBS-SNVBAGLBSA-NSMILESCC(C)C1=CC=CC([C@H](C)C2CC2)=C1O

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

889Drug interactionsStructured to mechanism, not free text

81Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

11+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Cipepofol, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account